Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
5.56 USD | +1.83% |
|
+20.65% | +30.28% |
Jul. 02 | Inozyme Pharma Says US FDA Granted Fast Track Designation to INZ-701 to Treat ABCC6 Deficiency | MT |
Jul. 02 | Inozyme Pharma Gets FDA Fast Track Designation for INZ-701 in ABCC6 Deficiency | DJ |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+30.28% | 338M | |
+25.73% | 46.56B | |
+45.49% | 41.67B | |
-0.48% | 41.16B | |
+34.26% | 32.4B | |
+20.66% | 28.18B | |
-6.35% | 28.1B | |
+49.01% | 14.52B | |
+47.43% | 13.74B | |
+1.72% | 12.17B |
- Stock Market
- Equities
- INZY Stock
- News Inozyme Pharma, Inc.
- Inozyme Pharma, Inc. Announces the Resignation of Stephen Basso as Senior Vice President, Finance, Effective May 14, 2021